100
Participants
Start Date
January 31, 2023
Primary Completion Date
December 31, 2024
Study Completion Date
June 30, 2025
Escitalopram
The US Food and Drug Administration(FDA) has only approved fluoxetine and escitalopram for the treatment of adolescent depression
Interpersonal Psychotherapy for Adolescent
Interpersonal Psychotherapy for Adolescent(IPT-A), A modified version of interpersonal psychotherapy, is shorter than the standard therapy duration (12-16 sessions), with a total of eight sessions, retaining the structure of the standard IPT but employing a series of strategies to extract the most important components to speed up the time process.
Escitalopram combined with psychotherapy
The subjects received adolescent interpersonal psychotherapy for adolescent(IPT-A) while taking medication
Escitalopram combined with rTMS
The subjects received Robotic navigational repetitive transcranial magnetic stimulation while taking medication
Escitalopram combined with sham rTMS
The subjects received sham Robotic navigational repetitive transcranial magnetic stimulation while taking medication
RECRUITING
The First Affiliated Hospital of Zhejiang University, Hangzhou
First Affiliated Hospital of Zhejiang University
OTHER